---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-22-000266"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2022-10-25T23:59:59+00:00"
generated_at: "2026-06-23T01:17:56.205821+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zoetis appoints Glenn David as EVP of U.S. Ops, Diagnostics, BioDevices; Jamie Brannan to International Ops

## Summary
- Glenn David becomes EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices effective Nov 1, 2022.
- Jamie Brannan appointed EVP and Group President, International Operations and Aquaculture (PHARMAQ) effective same date.
- Wafaa Mamilli, Chief Digital and Technology Officer, adds oversight of China, Brazil and Precision Animal Health.

## SEC filing metadata
- accession: 0001555280-22-000266
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2022-10-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/zts-20221024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-22-000266
- JSON: https://secwatch.observer/filing/0001555280-22-000266.json
- Plain text: https://secwatch.observer/filing/0001555280-22-000266.txt

## Key facts
- Executive change
  Wafaa Mamilli changed role as Chief Digital and Technology Officer at Zoetis Inc..
  - Action: assume oversight
  - Role: Chief Digital and Technology Officer
  source text: Wafaa Mamilli, the Company’s Chief Digital and Technology Officer, will also assume oversight of China, Brazil and Precision Animal Health, effective November 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm
- Executive change
  Jamie Brannan was appointed as Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ) at Zoetis Inc..
  - Action: appointed
  - Role: Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ)
  source text: the Company has appointed Jamie Brannan, who currently serves as the Company’s President, International Operations, as the Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ), effective November 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm
- Executive change
  Glenn David was appointed as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc..
  - Action: appointed
  - Role: Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices
  source text: Zoetis Inc. (the “Company”) appointed Glenn David as the Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.